Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemption Study of the ProDisc-L Total Disc Replacement Compared with Circumferential Arthrodesis for the Treatment of Two-Level Lumbar Degenerative Disc Disease-Reference-Cited by-同舟云学术

Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemption Study of the ProDisc-L Total Disc Replacement Compared with Circumferential Arthrodesis for the Treatment of Two-Level Lumbar Degenerative Disc Disease

Published:2011-04 Issue:8 Volume:93 Page:705-715
ISSN:0021-9355
Container-title:The Journal of Bone & Joint Surgery
language:en
Short-container-title:The Journal of Bone & Joint Surgery

Author:

Delamarter Rick,Zigler Jack E.,Balderston Richard A.,Cammisa Frank P.,Goldstein Jeffrey A.,Spivak Jeffrey M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Orthopedics and Sports Medicine,General Medicine,Surgery

Reference20 articles.

1. Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 7: intractable low-back pain without stenosis or spondylolisthesis

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Appropriateness and Quality of Composite Endpoint Use and Reporting in Spine Surgery;JBJS Reviews;2024-07

2. The Scientific Evidence for Lumbar Total Disk Replacement Surgery;Indian Spine Journal;2024-07

3. The fragility index and reverse fragility index of FDA investigational device exemption trials in spinal fusion surgery: a systematic review;European Spine Journal;2024-05-27

4. Preoperative conservative treatment is insufficiently described in clinical trials of lumbar fusion: a scoping review;European Spine Journal;2023-10-06

5. Total Disc Replacement in Lumbar Degenerative Disc Diseases;Core Techniques of Minimally Invasive Spine Surgery;2023